How to provide feedback As a broader consultation process in relation to new technologies has already been undertaken, feedback should be limited to the matters covered by the proposed amendments. Proposals to amend the classification of contained dealings have not been the subject of previous consultation, and for these further information is sought. The Consultation RIS describes three options available through this consultation: Option 1 retain the current GT Regulations – Option 2 amend the GT Regulations by introducing all elements of the draft – amendments, as detailed in full in section 3 of the Consultation RIS Option 3 - the GT Regulations by introducing some, but not all, of the amendment elements from Option 2. Comments and submissions that address any or all of the options and consultation questions below are welcome. You are not required to address all options; however, you should address the questions for your preferred option. Consultation questions What is your preferred option? Please explain why. Do the draft amendments clearly implement the measures described in Section 3 of the Consultation RIS? If not, which areas of the draft amendments do you think require additional clarification, and what clarification is needed? If your preferred option is Option 3, please indicate which amendments (or parts thereof) you support being progressed and why. What are the costs and benefits to you or your organisation from the proposed amendments? Please describe these compared to current arrangements, for each area of amendment: Clarifying the GT Regulations to take technological developments into account (i.e. in relation to SDN-1, SDN-2, ODM and RNAi) Repeal of Schedule 1 item 1, specifically whether you currently work with organisms that are not GMOs solely because of this item Updating the categorisation of contained dealings with GMOs Clarifying the regulatory status of organisms derived from GMOs that are not themselves GMOs minor administrative changes. Are the proposals to change the classification of certain and exempt dealings (identified in Appendix B of the Consultation RIS) commensurate with any risks to the health and safety of people and the environment posed by the dealings? Are there any features in the options presented that you have concerns with? Or, are there any particular features that you believe should be included? Please explain why and give substantiating evidence where possible. To support further analysis of impacts, particularly changes to regulatory burden, OGTR encourages submitters to provide information on how the amendment proposals could directly impact them, including:
How to provide feedback As a broader consultation process in relation to new technologies has already been undertaken, feedback should be limited to the matters covered by the proposed amendments. Proposals to amend the classification of contained dealings have not been the subject of previous consultation, and for these further information is sought. The Consultation RIS describes three options available through this consultation: Option 1 – retain the current GT Regulations Option 2 – amend the GT Regulations by introducing all elements of the draft amendments, as detailed in full in section 3 of the Consultation RIS Option 3 - the GT Regulations by introducing some, but not all, of the amendment elements from Option 2. Comments and submissions that address any or all of the options and consultation questions below are welcome. You are not required to address all options; however, you should address the questions for your preferred option. Consultation questions What is your preferred option? Please explain why. Do the draft amendments clearly implement the measures described in Section 3 of the Consultation RIS? If not, which areas of the draft amendments do you think require additional clarification, and what clarification is needed? If your preferred option is Option 3, please indicate which amendments (or parts thereof) you support being progressed and why. What are the costs and benefits to you or your organisation from the proposed amendments? Please describe these compared to current arrangements, for each area of amendment: Clarifying the GT Regulations to take technological developments into account (i.e. in relation to SDN-1, SDN-2, ODM and RNAi) Repeal of Schedule 1 item 1, specifically whether you currently work with organisms that are not GMOs solely because of this item Updating the categorisation of contained dealings with GMOs Clarifying the regulatory status of organisms derived from GMOs that are not themselves GMOs minor administrative changes. Are the proposals to change the classification of certain and exempt dealings (identified in Appendix B of the Consultation RIS) commensurate with any risks to the health and safety of people and the environment posed by the dealings? Are there any features in the options presented that you have concerns with? Or, are there any particular features that you believe should be included? Please explain why and give substantiating evidence where possible. To support further analysis of impacts, particularly changes to regulatory burden, OGTR encourages submitters to provide information on how the amendment proposals could directly impact them, including: